Clinicians should evaluate for contraindications specific to GLP-1 receptor agonists, including: Personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 History of pancreatitis or gallbladder disease Severe gastroparesis or gastrointestinal disease History of suicidal ideation or behavior Pregnancy or planned pregnancy (pregnancy testing when appropriate) Diabetic retinopathy (requires monitoring in patients with diabetes) Baseline investigations should include TSH, free T4, complete metabolic panel, lipid profile, and hemoglobin A1c (if diabetic or prediabetic)
682-P: Novel dual glucagon and glucagon-like peptide-1 receptor agonist LY3305677 improves glucose control, reduces body weight, and increases energy expenditure in mice
Do not freeze reconstituted solution as this can degrade the peptide [8]
Also, be aware that red yeast rice may aggravate symptoms of a neurological disorder, as described in a recent case report noted in the Concerns and Cautions section of the Red Yeast Rice Review
With the help of LifeMDs technology, we are creating customized care journeys that foster a close patient-provider relationship and provide more personalized support." GLP-1 receptor agonists are an injectable non-insulin type 2 diabetes medication that are FDA approved to help lower blood sugar and aid in weight management
